Population pharmacokinetics is playing an increasing role in clinical drug
development. An overview of the population approach, including software and
the advantages and limitations of the approach compared to the traditional
approach to pharmacokinetic studies, is given. This paper also documents h
ow the area has evolved over the past 15 years and addresses some of the is
sues that have arisen over the design and conduct of population studies. Fi
nally, some alternative applications of the population approach are given f
or areas other than clinical drug development.